Dr Adam N Summers, MD in Millersville, MD - Plastic Surgery

Dr Adam N Summers, MD is a Plastic Surgery physician based in Millersville, Maryland. Dr Adam N Summers is licensed to practice in Maryland (license number D0055340) and his current practice location is 1520 Jabez Run, Millersville, Maryland. He can be reached at his office (for appointments etc.) via phone at (410) 553-9444.

NPI number for Dr Adam N Summers is 1275584591 and his current mailing address is 1520 Jabez Run, Millersville, Maryland. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1275584591.

Contact Information

	Dr Adam N Summers, MD
	1520 Jabez Run, Millersville, MD 21108-2005
	(410) 553-9444
	Not Available

Physician's Profile

Full Name	Dr Adam N Summers
Gender	Male
Speciality	Plastic Surgery
Location	1520 Jabez Run, Millersville, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1275584591
Provider Enumeration Date: 05/12/2006
Last Update Date: 06/12/2023

Medical Identifiers

Medical identifiers for Dr Adam N Summers such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1275584591	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208200000X	Plastic Surgery	D0055340 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Adam N Summers is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Adam N Summers, MD 1520 Jabez Run, Millersville, MD 21108-2005 Ph: (410) 553-9444	Dr Adam N Summers, MD 1520 Jabez Run, Millersville, MD 21108-2005 Ph: (410) 553-9444

News Archive

Valeant enters into definitive agreement to acquire Sprout Pharmaceuticals

Valeant Pharmaceuticals International, Inc. and Sprout Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a wholly-owned subsidiary of Valeant will acquire Sprout, on a debt-free basis, for approximately $1 billion in cash, plus a share of future profits based upon the achievement of certain milestones.

NHS productivity in England increases by 3.2%, new study reveals

A new study by researchers at the Centre for Health Economics, University of York, reveals the productivity of the NHS in England increased by 3.2 per cent in the first year of the Coalition administration.

German market leader for radiation sterilization set to expand in the UK

BGS Beta-Gamma-Service, the German market leader for radiation sterilization, is set to expand its activities in the UK and will promote its services for the first time at Health GB Manchester from 30 April to 2 May.

Researchers uncover neurological basis of speech motor control

A team of researchers at UC San Francisco has uncovered the neurological basis of speech motor control, the complex coordinated activity of tiny brain regions that controls our lips, jaw, tongue and larynx as we speak.

Anyone can be affected by mouth cancer

Mouth cancer (also called oral cancer) is a malignant growth which can occur in any part of the mouth including the lips and tongue.

Dr Adam N Summers, MD - Plastic Surgery in Millersville, MD